J Breast Cancer.
2020 Feb;23(1):113-114. 10.4048/jbc.2020.23.e6.
Erratum: A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
- Affiliations
-
- 1Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
- 2Daegu Gyeongbuk Institute of Science & Technology, Daegu, Korea.
- 3Interdisciplinary Graduate Program in Genetic Engineering, Seoul National University College of Natural Science, Seoul, Korea.
- 4Bertis Inc. Korea, Seongnam, Korea.
- KMID: 2470888
- DOI: http://doi.org/10.4048/jbc.2020.23.e6
Abstract
- In the article, "A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer" in Volume 22(4), page 579-586 was error in the table. In Table 1, the value of pN0 was incorrectly listed as 29 (56.9) in "˜diagnosed as normal by biomarker' and corrected to 39 (76.5). The authors apologize for any inconvenience that this may have caused.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer
- Research of New Biomarker for Breast Cancer Using Proteomic Patterns
- Erratum: Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients
- Detection of Micrometastasis in Peripheral Blood of Breast Cancer Patients Using RT- PCR Assay: Comparison of MUC1, CK19 and hMMG
- Erratum: Lentivirus-Mediated Short-Hairpin RNA Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer
